Baillie Gifford & Co
BIOA

Baillie Gifford & Co’s BioAmber Inc. BIOA Stock Holding History

Baillie Gifford & Co’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-579,540
Closed -$1.49M – 207
2017
Q2 		$1.49M Hold
579,540
– – ﹤0.01% 195
2017
Q1 		$1.34M Hold
579,540
– – ﹤0.01% 194
2016
Q4 		$3.19M Hold
579,540
– – 0.01% 186
2016
Q3 		$2.46M Hold
579,540
– – ﹤0.01% 188
2016
Q2 		$1.73M Hold
579,540
– – ﹤0.01% 188
2016
Q1 		$2.43M Hold
579,540
– – ﹤0.01% 187
2015
Q4 		$3.58M Hold
579,540
– – 0.01% 167
2015
Q3 		$3.1M Buy
579,540
+91,400
+19% +$604K 0.01% 176
2015
Q2 		$4.2M Buy
488,140
+442,200
+963% +$4.04M 0.01% 168
2015
Q1 		$400K Buy
+45,940
New +$404K ﹤0.01% 191

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co's BIOA Position: Q3 2017 in Review

Baillie Gifford & Co sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 579,540 shares — an estimated $1.49M sold.

Baillie Gifford & Co first reported a position in BIOA in Q1 2015 and held it in 10 quarters. The position peaked at $4.2M in Q2 2015. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

  • Baillie Gifford & Co reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
  • Baillie Gifford & Co sold 579,540 BioAmber Inc. shares in Q3 2017, an estimated $1.49M.
  • Baillie Gifford & Co first reported a position in BioAmber Inc. in Q1 2015 and held it in 10 quarters.
  • Baillie Gifford & Co's BioAmber Inc. position peaked at $4.2M in Q2 2015.
  • 30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Baillie Gifford & Co's 13F filing for Q3 2017, filed 20 Oct 2017.